---
title: "Citi Sticks to Their Hold Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298520232.md"
description: "Citi analyst Laura Sutcliffe maintained a Hold rating on Resmed Inc CHESS Depositary Interests (10 CDIs per ord.sh) with an A$33.00 price target. Sutcliffe, a 3-star analyst covering Healthcare, contrasts with the broader market consensus, which rates Resmed as a Strong Buy with an average price target of A$38.84."
datetime: "2026-09-10T01:05:46.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298520232.md)
  - [en](https://longbridge.com/en/news/298520232.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298520232.md)
generator: "portal-rs"
---

# Citi Sticks to Their Hold Rating for Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD)

Citi analyst Laura Sutcliffe maintained a Hold rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh today and set a price target of A$33.00.

According to TipRanks, Sutcliffe is a 3-star analyst with an average return of 1.3% and a 50.29% success rate. Sutcliffe covers the Healthcare sector, focusing on stocks such as CSL, Telix Pharmaceuticals, and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh.

Currently, the analyst consensus on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh is a Strong Buy with an average price target of A$38.84.

### Related Stocks

- [RMD.US](https://longbridge.com/en/quote/RMD.US.md)
- [RMD.AU](https://longbridge.com/en/quote/RMD.AU.md)
- [CSL.AU](https://longbridge.com/en/quote/CSL.AU.md)
- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)
- [CSLLY.US](https://longbridge.com/en/quote/CSLLY.US.md)
- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)

## Related News & Research

- [Saudi Central Bank Increases Position in ResMed Inc. $RMD](https://longbridge.com/en/news/298289532.md)
- [Peter Farrell Sells 970 Shares of ResMed (NYSE:RMD) Stock](https://longbridge.com/en/news/298109393.md)
- [Citi Keeps Their Hold Rating on Cochlear  (CHEOF)](https://longbridge.com/en/news/298516761.md)
- [Citi Reaffirms Their Buy Rating on Pro Medicus Limited (PMCUF)](https://longbridge.com/en/news/298518238.md)
- [Macquarie Keeps Their Hold Rating on Region Group (SCPAF)](https://longbridge.com/en/news/298185411.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**